JIC Investment

JIC Investment

JIC Investment was founded in 2012 as a wholly owned subsidiary of China Jianyin Investment (JIC), a large state-owned investment corporation under China's central government. The firm was structured to house JIC's direct private equity and strategic acquisition activities, distinct from its parent's broader portfolio of securities, trust, and financial services subsidiaries. Its founding placed a dedicated operating team over a growing pool of industrial and consumer assets. The firm pursues a concentrated, control-oriented strategy. Its deployment spans industrial manufacturing, branded consumer goods, and healthcare, with a geographic footprint that extends from mainland China into developed markets in Asia-Pacific. The firm has executed its largest transactions in Australia, building a stable of wholly owned operating companies. The 2014 acquisition of GM Foods, a Sydney-based manufacturer of the Tibaldi-brand smallgoods and fresh-sliced deli-meat products, marked its first major international foray (per Australian Financial Review, 2014). In 2018, it acquired a majority stake in Nature's Care, a vitamin and supplement manufacturer based in Sydney, in a deal reported to value the business at roughly A$800 million, with co-investors Tamarix Partners (per Reuters, 2018). These assets are held directly on the firm's balance sheet. The firm has also acted as a developer of large-scale commercial real estate in Beijing through the Techno-Business District (TBD) mixed-use project. JIC Investment operates from its headquarters in Beijing. The firm does not disclose its total headcount or assets under management, consistent with the posture of many non-listed Chinese state investment subsidiaries. Its sole shareholder remains China Jianyin Investment Ltd, which provides the permanent capital base. In December 2022, the firm's philanthropic activities were formally aligned with its parent's foundation when the CICC Charity Foundation was designated to receive a donation associated with JIC's corporate social responsibility initiatives (per the firm's official communications, 2022). The parent company, JIC, was itself merged into China Central Huijin in a broader financial holding company restructuring in early 2023, though the operational independence of its direct-investment portfolio appears unchanged at this time. JIC Investment's structure is an uncommon hybrid: it holds permanent, never-out capital from a state parent but competes directly with Western private equity firms for buyout targets. It does not raise blind-pool funds from third-party LPs, nor does it recycle capital through exits. This balance-sheet model allows it to hold operating businesses with no clock for a liquidity event, yet it must still source, diligence, and manage international assets against sophisticated financial sponsors — executing in 2018 alongside Tamarix Partners for Nature's Care as a genuine co-investment consortium.